Follow
Kevin C. Ngan
Title
Cited by
Cited by
Year
Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers
AD Warren, ST Gaylord, KC Ngan, M Dumont Milutinovic, GA Kwong, ...
Journal of the American Chemical Society 136 (39), 13709-13714, 2014
642014
Ultrasensitive detection of ricin toxin in multiple sample matrixes using single-domain antibodies
ST Gaylord, TL Dinh, ER Goldman, GP Anderson, KC Ngan, DR Walt
Analytical chemistry 87 (13), 6570-6577, 2015
542015
Profiling the landscape of drug resistance mutations in neosubstrates to molecular glue degraders
PM Gosavi, KC Ngan, MJR Yeo, C Su, J Li, NZ Lue, SM Hoenig, BB Liau
ACS Central Science 8 (4), 417-429, 2022
352022
Using antigen–antibody binding kinetic parameters to understand single-molecule array immunoassay performance
TL Dinh, KC Ngan, CB Shoemaker, DR Walt
Analytical chemistry 88 (23), 11335-11339, 2016
302016
Base editor scanning charts the DNMT3A activity landscape
NZ Lue, EM Garcia, KC Ngan, C Lee, JG Doench, BB Liau
Nature chemical biology 19 (2), 176-186, 2023
232023
Activity-based CRISPR scanning uncovers allostery in DNA methylation maintenance machinery
KCH Ngan, SM Hoenig, HS Kwok, NZ Lue, PM Gosavi, DA Tanner, ...
Elife 12, e80640, 2023
102023
Rapid and ultrasensitive detection of botulinum neurotoxin serotype A1 in human serum and urine using single-molecule array method
TL Dinh, KC Ngan, CB Shoemaker, DR Walt
Forensic Toxicology 35, 179-184, 2017
102017
CRISPR‐Suppressor scanning for systematic discovery of drug‐resistance mutations
KC Ngan, NZ Lue, C Lee, BB Liau
Current protocols 2 (12), e614, 2022
42022
Integrative approaches to expand the utility of CRISPR tiling mutagenesis screens for biological discovery
KCH Ngan
Harvard University, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–9